Compound ID | 2158
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Lipopolysaccharide synthesis inhibitor. Inhibits lipooligosaccharide phosphoethanolamine transferase A (EptA; previously LptA); EptA inhibitor |
| Target Pathogen: | Active against Neisseria gonorrhoeae |
| Combined with other compounds: | Yes |
| Description: | Synthetic anti-EptA compound that ehances antibacterial activity of polymyxin B |
| Year first mentioned: | 2022 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://academic.oup.com/jac/article/77/9/2441/6622052?searchresult=1 |
| Patent: | Australian Provisional Patent Application No. 2021903584 |